Clinical Pharmacokinetic and Metabolism of PET Radiotracers for Imaging P-glycoprotein in Chemoresistant Tumor of Colorectal Cancer

Author(s): Mariangela Cantore, Elena Capparelli, Francesco Berardi, Roberto Perrone, Nicola Antonio Colabufo

Journal Name: Current Drug Metabolism

Volume 12 , Issue 10 , 2011

Become EABM
Become Reviewer


The pharmacological treatment of colorectal tumour leads to MultiDrug Resistance due to overexpression of several ABC transporters such as P-glycoprotein and some Multidrug associated Resistance Proteins (MRPs) that are able to efflux the chemotherapeutic agent out of the cell. A strategy to reverse MDR is the co-administration of antineoplastic agent with a P-glycoprotein inhibitor. These inhibitors are an useful tool for investigating, by PET, the expression and the activity of P-gp and MRPs that are overexpressed in chemoresistant colorectal tumor cells. In this review will be focused the aspect on P-gp and MRPs ligands employed as PET radiotracers considering their pharmacokinetic pharmacodynamic profile and their selectivity towards ABC transporters involved in chemoresistant cell of colorectal tumour.

Keywords: Colorectal, cancer, PET, P-glycoprotein, MultiDrug Resistance, 11-C radiotracers, Everted gut sac, neuroblastoma, epipodophyllotoxins, Nucleotide Binding domains (NBDs)

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2011
Page: [985 - 988]
Pages: 4
DOI: 10.2174/138920011798062292
Price: $65

Article Metrics

PDF: 7